This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Epam (EPAM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Epam (EPAM) closed at $280.07, marking a +1.2% move from the previous day.
Should You Invest in the Invesco DWA Technology Momentum ETF (PTF)?
by Zacks Equity Research
Sector ETF report for PTF
Epam (EPAM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Epam (EPAM) closed at $306.65, marking a +1.02% move from the previous day.
EPAM Shares Continue to Fall on Ukraine Crisis & Russia Exit
by Zacks Equity Research
EPAM Systems' (EPAM) share price has plunged significantly in the last two weeks on growing concerns over business disruptions amid the ongoing war between Russia and Ukraine.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
EPAM Systems' (EPAM) Q4 Earnings and Revenue Beat Estimates
by Zacks Equity Research
EPAM Systems' (EPAM) fourth-quarter results reflect benefits from continuous growth across all of its operating verticals and geographies.
Epam (EPAM) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Epam (EPAM) delivered earnings and revenue surprises of 10.40% and 2.19%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
EPAM Systems (EPAM) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
EPAM's (EPAM) Q4 results are likely to reflect benefits from growing demand for its products and services as well as contributions from acquisitions, including Emakina.
Epam (EPAM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Epam (EPAM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ASGN Inc (ASGN) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
ASGN Inc (ASGN) delivered earnings and revenue surprises of 14.81% and 2.37%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Epam (EPAM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Epam (EPAM) closed the most recent trading day at $456.04, moving +1.77% from the previous trading session.
Should You Invest in the Invesco DWA Technology Momentum ETF (PTF)?
by Zacks Equity Research
Sector ETF report for PTF
Epam (EPAM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Epam (EPAM) closed the most recent trading day at $474.95, moving -1.94% from the previous trading session.
Epam (EPAM) Stock Moves -0.49%: What You Should Know
by Zacks Equity Research
In the latest trading session, Epam (EPAM) closed at $433.41, marking a -0.49% move from the previous day.
Epam (EPAM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Epam (EPAM) closed the most recent trading day at $543.06, moving +0.45% from the previous trading session.
Are You Looking for a Top Momentum Pick? Why Epam (EPAM) is a Great Choice
by Zacks Equity Research
Does Epam (EPAM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Fortinet (FTNT) Up 142% YTD: Will the Rally Continue in 2022?
by Zacks Equity Research
Fortinet (FTNT) stock is likely to continue upward momentum as the company sees solid demand for its security and networking products amid the ongoing pandemic crisis and remote working trend.
Tyler (TYL) Acquires University Inn Academic Suites Building
by Zacks Equity Research
Tyler (TYL) purchases University Inn Academic Suites building in Orono, Maine, to hire local talents and enhance job opportunities in STEAM fields across the town.
Mercury Systems (MRCY) Implements Poison-Pill Tactic for 1-Year
by Zacks Equity Research
Mercury Systems (MRCY) adopts one-year shareholder rights plan, commonly known as Poison Pill, to protect the long-term interests of its shareholders.
CDW Stock Surges 57% YTD: Will the Rally Continue in 2022?
by Zacks Equity Research
CDW Corporation (CDW) stock likely to continue upward momentum as the company witnesses solid demand for its products that enable remote working and operations continuity plans, thus boosting revenue growth for certain products.
DXC vs. EPAM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DXC vs. EPAM: Which Stock Is the Better Value Option?
Epam (EPAM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Epam (EPAM) closed at $663.08 in the latest trading session, marking a +0.39% move from the prior day.
Zacks.com featured highlights include: Boise Cascade, Photronics, HomeStreet, Daqo New Energy and EPAM Systems
by Zacks Equity Research
Zacks.com featured highlights include: Boise Cascade, Photronics, HomeStreet, Daqo New Energy and EPAM Systems.
Buy These 5 Low-Leverage Stocks to Keep Your Investments Safe
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not overburdened with debt. You can buy BCC, PLAB, HMST, DQ and EPAM
EPAM Acquires Optiva, Boosts Digital Transformation Portfolio
by Zacks Equity Research
The acquisition of Optiva Media is likely to enhance EPAM Systems' (EPAM) capabilities in digital strategy, engineering and creativity, thereby helping it to provide better user experiences.